Breztri Aerosphere is a combination inhaler that contains budesonide (an inhaled corticosteroid), glycopyrrolate (a long-acting muscarinic antagonist), and formoterol (a long-acting beta agonist). It's used for maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. Breztri is inhaled through the mouth and into the lungs twice per day every day. The most common side effects are upper respiratory tract infections and pneumonia. Breztri is brand name only and not available as a lower-cost generic.
Breztri is a combination inhaler containing three medications that work together so you can breathe more easily.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Tips for how to use Breztri:
Yes. Budesonide in Breztri is an inhaled corticosteroid (or steroid). It's purpose is to lower inflammation in the lungs, which helps to keep your airways open and help you breathe better.
Studies show Breztri can start to improve breathing within 5 minutes of taking a dose. But it can take several weeks before you notice a difference in how well it keeps COPD flare-ups under control. Keep in mind Breztri isn't recommended to treat a COPD attack or sudden trouble breathing. Talk with your pulmonologist if you have more questions about how long it takes for Breztri to work.
It might take about a day for most of budesonide, about 3 days for most of glycopyrrolate, and 2 days for most of formoterol to leave your body after an inhalation of Breztri. This time frame is estimated based on the half-life of each medication in Breztri. But keep in mind that you need to take Breztri twice daily for it to work well to control COPD.
Breztri has specifically only been studied in people with COPD, not asthma. There's not enough information to know whether Breztri is safe or works well for people with asthma. There are several other combination inhalers approved for asthma, including Trelegy Ellipta, that might be more appropriate. Talk with your pulmonologist if you have questions about combination inhalers for asthma.
No, Breztri and Trelegy Ellipta aren't the same. They're both combination inhalers that contains an ICS, LAMA, and LABA. But Breztri (budesonide / glycopyrrolate / formoterol) is only approved for COPD, while Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) is approved for COPD and asthma. In addition, Breztri is inhaled twice daily, whereas Trelegy Ellipta is inhaled once daily. Lastly, Breztriis a type of inhaler called a metered dose inhaler that delivers the medication as a mist. But Trelegy Ellipta is an Ellipta inhaler that delivers the medication as a dry powder. Talk to your pulmonologist if you have specific questions about the differences of each inhaler.
Your pulmonologist will likely prescribe you albuterol (Ventolin) as a rescue inhaler when you're taking Breztri. This is because Breztri is a long-acting medication that works over time to lessen inflammation and swelling in your lungs and open your airways. But it won't help if you have sudden trouble breathing during a COPD flare up. A rescue inhaler, such as albuterol (Ventolin), works quickly and can relieve sudden symptoms, such as coughing and wheezing. Ask your healthcare team if you have more questions about Breztri and rescue inhalers.
People using Breztri in clinical studies didn't report hair loss as a side effect. Contact your primary care provider if you notice signs of hair loss so they can help you figure out possible causes.
Weight gain wasn't reported in people taking Breztri in clinical studies. Breztri contains budesonide, which is a corticosteroid, and corticosteroids are known to cause weight gain especially when taken by mouth. But because Breztri is inhaled, it's unlikely to get absorbed into the rest of your body and cause weight gain. Talk with your primary care provider if you experience unexplained weight gain so they can help figure out a cause.
Breztri can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Don't use Breztri if you're experiencing a COPD flare-up because this medication won't provide immediate relief. Use a rescue inhaler, such as albuterol (Ventolin HFA), if you're having trouble breathing.
If you're using your rescue inhaler more often than usual, let your pulmonologist know because this could be a sign that your condition is getting worse. Don't use more doses Breztri than recommended because this won't improve your breathing. Rather, this can raise your risk for serious side effects, such as heart problems, tremors, and dizziness.
In addition, don't use Breztri with other inhalers containing a LABA, such as Serevent Diskus (salmeterol) or formoterol (Perforomist). Doing so can also worsen side effects.
Breztri isn't FDA-approved to treat asthma. Don't use this medication if you have asthma.
Breztri contains budesonide, a steroid medication. When inhaled, it can cause a fungal infection in your mouth and throat called thrush. The risk is highest during the first 3 months after you start this medication. To lower your risk for thrush, rinse your mouth with water and spit after each inhalation of Breztri. If you develop thrush, your pulmonologist might prescribe you a medication to treat this condition and ask you to temporarily stop using Breztri. Let your pulmonologist know if you notice symptoms of thrush, such as white patches in your mouth, cotton-like feeling in your mouth, pain while eating or swallowing, or loss of taste.
Inhaled medications, including Breztri, can sometimes cause a muscle spasm in your lungs. This can lead to difficulty breathing, wheezing, cough, and chest discomfort. If you have a hard time breathing after inhaling Breztri, use your rescue inhaler and get medical attention right away.
Allergic reactions to Breztri are possible. These reactions can include life-threatening facial swelling, shock, and anaphylaxis (closing of the throat). Get medical attention right away if you notice hives, rash, red skin, swelling of the lips or tongue, or difficulty breathing after you use Breztri.
Like all corticosteroid-containing medications, Breztri can weaken your immune system and raise your risk for infections, including upper respiratory infections and pneumonia. Your risk for infections is higher if you're also taking other medications that also weaken your immune system. If you're currently being treated for a serious infection, such as tuberculosis, let your pulmonologist know. They might need to consider a different medication for your condition until you get better. Let your pulmonologist or primary care provider know right away if you have symptoms of infections, such as fever, chills, or body aches.
Use Breztri only as directed. Don't use more than the maximum number of inhalations each day. Doing so can cause more of the steroid to be absorbed into the body and raise your risk for symptoms such as higher blood sugar or blood pressure.
On the other hand, if you're transitioning to Breztri from oral steroids, you might experience symptoms of low steroid hormone, such as stomach pain, loss of appetite, and nausea. When you transition to Breztri, your pulmonologist will work with you to lower your dose of oral steroids slowly over time to prevent these side effects.
Although rare, people using inhaled steroids or anticholinergics over a long period of time have reported having higher pressure in the eyes, glaucoma, and cataracts. Since Breztri contains budesonide (a steroid) and glycopyrrolate (an anticholinergic), talk to your optometrist before using Breztri if you have glaucoma or cataracts because they might ask you to come in more often for eye exams. Also speak with them if you notice any changes to your vision while using the medication.
The formoterol in Breztri might cause changes in your blood pressure, heart rate, and heart rhythm. But these side effects are typically unlikely to happen if you're taking the recommended dose of Breztri. Your pulmonologist or cardiologist might ask you to regularly check your blood pressure and heart rate at home if you have high blood pressure or other heart problems. Don't use Breztri more often than recommended. If you find that you need to use Breztri more often, let your care team know so they can see if you need any changes to your treatment plan. Tell your pulmonologist if you have dizziness, fatigue, tremor, rapid heartbeat, or weakness after you use Breztri.
Formoterol in Breztri can cause the potassium levels in your blood to drop too low. In most cases, this happens if you use more Breztri than recommended. Drops in blood potassium levels are typically mild and your levels should go back to usual with time. Sometimes, low potassium can cause tiredness, weakness, muscle cramps, a racing heart, and a "pins and needles" feeling in your hands and feet. Tell your prescriber if you experience any of these symptoms while you're using Breztri. Also let your prescriber know if you need to use Breztri more often than instructed. Your treatment plan might need to be adjusted to better control your symptoms.
Breztri should be used cautiously by people who have prostate problems or urinary retention, because glycopyrrolate in Breztri can cause difficulty urinating. Contact your prescriber if you notice difficulty urinating while using this medication.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 120 inhalations of 160mcg/9mcg/4.8mcg | 1 inhaler | $0.00 | $0.00 |
Each inhalation of Breztri contains 160 mcg of budesonide, 9 mcg of glycopyrrolate, and 4.8 mcg of formoterol.
The typical dose is 2 inhalations by mouth twice per day (in the morning and in the evening).
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Breztri will not be safe for you to take.